Allworth Financial’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
Allworth Financial's AMPH Position: Q2 2026 in Review
Allworth Financial increased its Amphastar Pharmaceuticals (AMPH) stake by 1,209% in Q2 2026, buying an estimated $10.5K and bringing the position to 563 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3628.
Allworth Financial first reported a position in AMPH in Q4 2021 and has held it in 19 quarters since. The position peaked at $90.9K in Q4 2023. 211 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.
- Allworth Financial held 563 shares of Amphastar Pharmaceuticals worth $11.4K as of Q2 2026.
- Allworth Financial bought 520 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $10.5K.
- Amphastar Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3628 holding.
- Allworth Financial first reported a position in Amphastar Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
- Allworth Financial's Amphastar Pharmaceuticals position peaked at $90.9K in Q4 2023.
- 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.
Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.